Cargando…
Antiretroviral Drug Resistance Mutations among HIV Treatment Failure Patients in Tehran, Iran
BACKGROUND: This study aimed to determine drug resistance mutations in patients with virological failure and find correlation between HIV drug resistance test and viral load. METHODS: Blood sample was collected from 51 patients who suspicious treatment failure in the center of Imam Khomeini Hospital...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Tehran University of Medical Sciences
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5632328/ https://www.ncbi.nlm.nih.gov/pubmed/29026792 |
_version_ | 1783269680451944448 |
---|---|
author | FARROKHI, Molood MOALLEMI, Samaneh SHIRKOOHI, Reza GOLMOHAMMADI, Reza AHSANI-NASAB, Sara SARDASHTI, Sara ABBASIAN, Ladan BAESI, Kazem MOHRAZ, Minoo |
author_facet | FARROKHI, Molood MOALLEMI, Samaneh SHIRKOOHI, Reza GOLMOHAMMADI, Reza AHSANI-NASAB, Sara SARDASHTI, Sara ABBASIAN, Ladan BAESI, Kazem MOHRAZ, Minoo |
author_sort | FARROKHI, Molood |
collection | PubMed |
description | BACKGROUND: This study aimed to determine drug resistance mutations in patients with virological failure and find correlation between HIV drug resistance test and viral load. METHODS: Blood sample was collected from 51 patients who suspicious treatment failure in the center of Imam Khomeini Hospital, Tehran, Iran in 2015. Viral voluntary counseling and testing load test was done and the patients with viral load above 1000 copies choose for detection of drug resistance mutations by genotyping method (29 patients). RESULTS: The majority of patients (82.75) harbored the HIV subtype CRF 35 A-D. The 86.2% patients compromised at least one resistance mutation. The analysis of reverse transcriptase showed M184V (68.9%), T215YISF (44.8%), K103N (27.6%) and the analysis results of protease revealed G73SC (13.8%) and I47VA (6.9%). Eventually, the significant correlation between viral load and drug resistance was found. CONCLUSION: The result of our research stress the significance of recognizing drug resistant on time that prohibits the accumulation of drug resistance mutation and circulates the resistance strain of HIV-1 virus and the importance of national study according to the reliable findings for treatment guidelines. |
format | Online Article Text |
id | pubmed-5632328 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Tehran University of Medical Sciences |
record_format | MEDLINE/PubMed |
spelling | pubmed-56323282017-10-12 Antiretroviral Drug Resistance Mutations among HIV Treatment Failure Patients in Tehran, Iran FARROKHI, Molood MOALLEMI, Samaneh SHIRKOOHI, Reza GOLMOHAMMADI, Reza AHSANI-NASAB, Sara SARDASHTI, Sara ABBASIAN, Ladan BAESI, Kazem MOHRAZ, Minoo Iran J Public Health Original Article BACKGROUND: This study aimed to determine drug resistance mutations in patients with virological failure and find correlation between HIV drug resistance test and viral load. METHODS: Blood sample was collected from 51 patients who suspicious treatment failure in the center of Imam Khomeini Hospital, Tehran, Iran in 2015. Viral voluntary counseling and testing load test was done and the patients with viral load above 1000 copies choose for detection of drug resistance mutations by genotyping method (29 patients). RESULTS: The majority of patients (82.75) harbored the HIV subtype CRF 35 A-D. The 86.2% patients compromised at least one resistance mutation. The analysis of reverse transcriptase showed M184V (68.9%), T215YISF (44.8%), K103N (27.6%) and the analysis results of protease revealed G73SC (13.8%) and I47VA (6.9%). Eventually, the significant correlation between viral load and drug resistance was found. CONCLUSION: The result of our research stress the significance of recognizing drug resistant on time that prohibits the accumulation of drug resistance mutation and circulates the resistance strain of HIV-1 virus and the importance of national study according to the reliable findings for treatment guidelines. Tehran University of Medical Sciences 2017-09 /pmc/articles/PMC5632328/ /pubmed/29026792 Text en Copyright© Iranian Public Health Association & Tehran University of Medical Sciences http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article FARROKHI, Molood MOALLEMI, Samaneh SHIRKOOHI, Reza GOLMOHAMMADI, Reza AHSANI-NASAB, Sara SARDASHTI, Sara ABBASIAN, Ladan BAESI, Kazem MOHRAZ, Minoo Antiretroviral Drug Resistance Mutations among HIV Treatment Failure Patients in Tehran, Iran |
title | Antiretroviral Drug Resistance Mutations among HIV Treatment Failure Patients in Tehran, Iran |
title_full | Antiretroviral Drug Resistance Mutations among HIV Treatment Failure Patients in Tehran, Iran |
title_fullStr | Antiretroviral Drug Resistance Mutations among HIV Treatment Failure Patients in Tehran, Iran |
title_full_unstemmed | Antiretroviral Drug Resistance Mutations among HIV Treatment Failure Patients in Tehran, Iran |
title_short | Antiretroviral Drug Resistance Mutations among HIV Treatment Failure Patients in Tehran, Iran |
title_sort | antiretroviral drug resistance mutations among hiv treatment failure patients in tehran, iran |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5632328/ https://www.ncbi.nlm.nih.gov/pubmed/29026792 |
work_keys_str_mv | AT farrokhimolood antiretroviraldrugresistancemutationsamonghivtreatmentfailurepatientsintehraniran AT moallemisamaneh antiretroviraldrugresistancemutationsamonghivtreatmentfailurepatientsintehraniran AT shirkoohireza antiretroviraldrugresistancemutationsamonghivtreatmentfailurepatientsintehraniran AT golmohammadireza antiretroviraldrugresistancemutationsamonghivtreatmentfailurepatientsintehraniran AT ahsaninasabsara antiretroviraldrugresistancemutationsamonghivtreatmentfailurepatientsintehraniran AT sardashtisara antiretroviraldrugresistancemutationsamonghivtreatmentfailurepatientsintehraniran AT abbasianladan antiretroviraldrugresistancemutationsamonghivtreatmentfailurepatientsintehraniran AT baesikazem antiretroviraldrugresistancemutationsamonghivtreatmentfailurepatientsintehraniran AT mohrazminoo antiretroviraldrugresistancemutationsamonghivtreatmentfailurepatientsintehraniran |